SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.50 (0.68%)
Bid:
72.00
Ask:
75.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

Interim Management Statement

12 Sep 2025 07:00

RNS Number : 0239Z
British Smaller Companies VCT PLC
12 September 2025
Β 

British Smaller Companies VCT plc

Interim Management Statement for the quarter ended 30 June 2025

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 30 June 2025. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

In the quarter to 30 June 2025 the Company's Net Asset Value (NAV) per share increased by 0.80 pence, a 1.0 per cent increase on the opening NAV per share. At 30 June 2025 the NAV per ordinary share totalled 81.35 pence.Β 

The Company's Total Return at 30 June 2025 was up 0.80 pence, to 265.50 pence per ordinary share.

During the quarter, the Company invested Β£2.4 million into new investment S4labour; and invested a further Β£0.6 million into existing portfolio companies Force24 and Relative Insight. Subsequent to the quarter end, the Company invested Β£1.8 million into new portfolio company DynaRisk and Β£3.9 million into three existing portfolio companies, AutomatePro, Fuuse and Panintelligence. This takes the total amount invested so far this year to Β£8.7 million.

Following the period end, the sale of the trade and liabilities of Wooshii was completed. No proceeds were received on exit, in line with its minimal carrying value at the period end.

The final allotment of the Company's 2024/25 fundraise took place on the first day of the quarter, with Β£29.6 million allotted on 1 April 2025.

Performance

The table below sets out movements in key metrics for the Company.Β 

Β 

Β 

31 March 2025

Increase in Value

Shares issued

Buyback of shares

Movement

In Period

30 June 2025

Net Assets (Β£m)

257.1

2.9

29.6

(1.2)

31.3

288.4

NAV per share (PPS)

80.55

0.80

-

-

0.80

81.35

Cumulative dividends paid (PPS)

184.15

-

-

-

-

184.15

Total Return (PPS)

264.70

0.80

-

-

0.80

265.50

Shares in issue

319,178,657

-

36,799,582

(1,495,509)

35,304,073

354,482,730

Cumulative dividends paid at 30 June 2025 were 184.15 pence per ordinary share (31 March 2025: 184.15 pence per ordinary share). Following the payment of the interim dividend of 2.00 pence per ordinary share on 25 July 2025, cumulative dividends paid are now 186.15 pence per ordinary share.

The movements in NAV and NAV per ordinary share are set out in the table below:

Β 

Β 

Β£m

Pence per

ordinary share

NAV at 31 March 2025

257.1

80.55

Increase in portfolio value

2.7

0.75

Net operating income

0.2

0.05

2.9

0.80

Issue/buy-back of shares

28.4

-

Total Return in the period

31.3

0.80

NAV at 30 June 2025

Β 

288.4

Β 

81.35

Β 

Dividends and shares in issue

On 1 April 2025 the Company issued 36,799,582 shares in relation to the second and final allotment from its 2024/25 fundraising.

Under its standing buyback authority, on 23 June 2025 the Company purchased 1,495,509 shares at 77.02 pence per share at a cost of Β£1.2 million. These shares are held in treasury.Β 

Post-period end, on 25 July 2025, a dividend of 2.00 pence per ordinary share for the year ending 31 March 2026 was paid, resulting in a corresponding reduction in the Company's NAV per ordinary share, adjusting the last reported NAV to 79.35 pence per ordinary share. Cumulative dividends paid are now 186.15 pence per ordinary share.

On 25 July 2025 the Company also issued 1,515,132 shares under the Company's Dividend Re-investment Scheme (DRIS). following which the Company's issued share capital consists of 355,997,862 ordinary shares with voting rights and 35,694,505 shares held in treasury.

Net assets

Net assets at 30 June 2025 comprised the following:

Β£000

% of net assets

Unquoted investments at fair value

159,047

55.2

Cash and money market funds

125,082

43.4

Other net assets

4,233

1.4

Net assets

288,362

100.0

Investments

The investment portfolio at 30 June 2025 comprised:

Valuation

Β£000

Cumulative valuation as a % of net assets

Matillion

21,462

7.4%

Unbiased

14,554

12.5%

Vypr

10,938

16.3%

Xapien

8,726

19.3%

AutomatePro

8,403

22.2%

SharpCloud

8,193

25.1%

Summize

7,871

27.8%

DrDoctor

6,409

30.0%

Workbuzz

6,304

32.2%

Force24

6,259

34.4%

99,119

34.4%

Other investments

59,928

55.2%

Total investments

159,047

55.2%

Β 

Portfolio performance

Over the quarter to 30 June 2025, the aggregate unquoted portfolio valuation has increased by Β£2.7 million. Several portfolio companies are demonstrating strong underlying growth of revenues, which has driven positive revaluation uplifts across several assets. This has been balanced by downward movements in the valuations of Matillion, driven by foreign exchange movements; Outpost, due to sector-specific challenges; and Wooshii, where, as noted above, the trade and liabilities were realised shortly after the period end.

Fundraising

On 22 August 2025, the Company announced its intention to launch a new joint offer for subscription for the tax year 2025/26 later this year, alongside British Smaller Companies VCT2 plc (together the "BSC VCTs"). The current intention is for the BSC VCTs, in aggregate, to raise up to Β£60 million, with over-allotment facilities of up to a further Β£25 million in aggregate, before issue costs. Any election for the Company to make use of its over-allotment facility will be subject to the decisions of the individual boards of the BSC VCTs at the relevant time.

A prospectus with full details of the proposed Offer is expected to be published on or around 25 September, with applications expected to open one week following publication. Once published, the prospectus will be available from the BSC VCTs' website, www.bscfunds.com.

Outlook

The outlook for the UK economy over the coming months remains unclear. Inflation continues to run above expectations, with recent figures showing ongoing price increases despite limited growth. The Bank of England is likely to cut interest rates further, while the Government is managing tight fiscal conditions.

Internationally, economic uncertainty is being driven by trade disputes and unpredictable policy decisions. US-China tensions remain high, with tariffs altering global trade patterns. The global economy is still vulnerable to external shocks, including energy price swings and geopolitical instability in regions such as Ukraine and the Middle East.

Despite this environment, the Manager is still finding strong investment opportunities in fast-growing, technology-led businesses. Demand from existing portfolio companies also remains high, with many looking to accelerate their growth. These factors support a cautiously optimistic outlook for the Company.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

12 September 2025

For further information please contact:

Marcus Karia YFM Equity Partners Tel: 0113 244 1000

Alex Collins Panmure Liberum Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
QRFGPUGGBUPAGAG
Date   Source Headline
1st Apr 20104:39 pmRNSIssue of Equity
30th Mar 20101:06 pmRNSOffer Update - Close of Offer
1st Mar 20108:42 amRNSPotential Transaction
29th Jan 20107:00 amRNSInterim Management Statement to 31 December 2009
8th Jan 20109:14 amRNSIssue of Equity
23rd Dec 20094:22 pmRNSTransaction in Own Shares
20th Nov 20097:00 amRNSHalf Yearly Report to 30 September 2009
14th Aug 20097:00 amRNSInterim Management Statement
14th Aug 20097:00 amRNSIssue of Equity and Total Voting Rights
7th Aug 20091:07 pmRNSAGM Statement
13th Jul 200910:29 amRNSDoc re. Annual Report for year ended 31 March 2009
8th Jul 20095:59 pmRNSDoc re. Circular to Shareholders
3rd Jul 20093:25 pmRNSTransaction in Own Shares
26th Jun 20093:42 pmRNSAnnual Financial Report - Replacement
26th Jun 20092:23 pmRNSAnnual Financial Report Announcment
11th Feb 200911:33 amRNSIssue of Equity and Total Voting Rights
20th Jan 20099:50 amRNSInterim Management Statement
15th Jan 20094:09 pmRNSIssue of Equity and New Articles - Amendment
15th Jan 20091:46 pmRNSIssue of Equity and New Articles
16th Dec 20088:47 amRNSInterim Report and Circular to Shareholders
20th Nov 200811:00 amRNSHalf Year Financial Statements
1st Oct 20089:16 amRNSTransaction in Own Shares
8th Aug 20089:33 amRNSInterim Management Statement
7th Aug 20084:39 pmRNSAGM Statement
15th Jul 20084:08 pmRNSAnnual Report and Accounts
11th Jul 200811:31 amRNSPurchase of Own Shares and To
3rd Jul 20088:47 amRNSUnaudited Preliminary Results
1st Jul 20089:59 amRNSDirector Change
1st May 20083:48 pmRNSIssue of Equity
7th Apr 20083:53 pmRNSAllotment of shares and TVR
3rd Apr 20084:31 pmRNSCirc re. Fund Manager
1st Apr 200812:53 pmRNSPurchase of shares and TVR
29th Feb 200812:57 pmRNSDirectorate Change
20th Feb 20083:21 pmRNSPurchase of own shares & TVR
14th Feb 20083:25 pmRNSPurchase of shares and TVR
6th Feb 20084:32 pmRNSEGM Statement
24th Jan 20084:11 pmRNSInterim Management Statement
4th Jan 20084:04 pmRNSOffer for Subscription
30th Nov 20071:21 pmRNSPurchase of shares and TVR
17th Oct 200710:25 amRNSInterim Results
28th Sep 20074:56 pmRNSShare Buyback & Voting Rights
6th Sep 20079:37 amRNSAnnouncement re Cozart plc
5th Sep 20075:02 pmRNSSale of holding in Cozart plc
9th Aug 20079:53 amRNSInterim Management Statement
8th Aug 200712:47 pmRNSPurchase of Own Shares
1st Aug 20071:55 pmRNSIssue of Equity
29th Jun 20074:54 pmRNSTotal Voting Rights
29th Jun 20074:50 pmRNSTransaction in Own Shares
22nd Jun 200712:28 pmRNSTotal Voting Rights
12th Jun 20072:42 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.